Interpace Biosciences Inc
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2011 | — | $59.5M | $64.3M |
| FY2012 | — | $35.6M | $52.8M |
| FY2013 | — | $32.5M | $45.6M |
| FY2014 | $27.2M | $25.3M | $23.1M |
| FY2015 | $7.2M | $15.2M | $8.3M |
| FY2016 | $7.9M | $4.8M | $602.0K |
| FY2017 | — | $7.8M | $15.2M |
| FY2018 | — | $22.7M | $6.1M |
| FY2019 | $2.7M | $18.4M | $2.3M |
| FY2020 | $3.7M | $-10.9M | $2.8M |
| FY2021 | $520.0K | $-42.4M | $2.7M |
| FY2022 | $1.8M | $-58.1M | $4.8M |
| FY2023 | — | $-57.4M | $5.6M |
| FY2024 | — | $-54.8M | $2.8M |
| FY2025 | — | $22.4M | $2.5M |